Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_4022_Библиотеки_им_академика_М_И_Перельмана
.pdf
Продукт Фолаты Продукт Фолаты Продукт Фолаты Продукт Фолаты
Капуста брюссель-
ская и кольраби
31,00 Булка сдобная 31,00 Хлеб ржаной
и пшеничный
зерновой
30,00 Шпик свиной 30,00
Молоко сухое 30,00 Крупа овсяная 29,00 Батон 28,00 Мука пшеничная,
в/с
27,10
Крупа перловая 24,00 Сыр «Российс-
кий»
23,50 Крупа «Геркулес»
и манная
23,00 Капуста цветная 23,00
Хлеб пшеничный 22,50 Печенье, сухари 21,00 Макароны, в/с 20,00 Крупа рисовая 19,00
Баклажаны 18,50 Лук зеленый 18,00 Перец сладкий
красный
17,00 Горох 16,00
Тыква 14,00 Мозги 14,00 Сыр плавленый 14,00 Свекла 13,00
Горошек зеленый 12,00 Треска 11,30 Помидоры 11,00 Масло сливочное 10,00
Оливки 10,00 Капуста белоко-
чанная
10,00 Ставрида 10,00 Земляника садо-
вая
10,00
Морковь красная 19,00 Лук репчатый 9,00 Сметана 8,50 Говядина 3,40
Арбуз, персики 8,00 Картофель 8,00 Кефир 7,80 Мясо кролика 7,70
Простокваша 7,40 Консервы рыбные 7,10 Яйцо куриное 7,00 Сок томатный 6,00
Редис, репа, дыня 6,00 Колбаса полукоп-
ченая
5,40 Баранина 5,10 Молоко коровье 5,00
Апельсины 5,00 Кура 4,30 Сосиски, колбаса
вареная
4,05 Огурцы, виноград 4,00
Грейпфруты,
абрикосы
3,00 Яблоки, груши 2,00 Дрожжи 0,60 Редька 0,03
472
ЛИТЕРАТУРА
Андрияшкин В.В., Антух Э.А., Бредер В.В. и др. Российские клиниче-
ские рекомендации по профилактике и лечению венозных тромбоэм-
болических осложнений у онкологических больных. URL: http://www.
phlebo-union.ru
Бокарев И.Н., Попова Л.В. Венозный тромбоэмболизм и тромбоэмбо-
лия легочной артерии. — М.: МИА, 2005. — 204 с.
Бокарев И.Н., Попова Л.В., Козлова Т.В. Тромбозы и противотромботи-
ческая терапия в клинической практике. — М.: МИА, 2009. — 512 с.
Кондратьева Т.Б. Неоплазмы и свертывание крови // Вестник Мос-
ковского онкологического общества. — 2004. — № 4. — С. 3–5.
Вертинский Е.Ф., Чиж С.А., Чиж А.С. Значение эхокардиографии
в комплексной диагностике тромбоэмболии легочной артерии // Ма-
териалы конференции. — 2002. — Т. 1. — С. 99–102.
Коган А.Е., Струкова С.М. Протеин С: механизмы активации и антико-
агулянтного действия // Биохимия. — 1993. — № 58 (6). — С. 827–844.
Российские клинические рекомендации по диагностике, лечению, про-
филактике венозных тромбоэмболических осложнений / Координато-
ры проекта: В.С. Савельев, Е.И. Чазов, Е.И. Гусев, А.И. Кириенко //
Флебология. — 2010. — Т. 4. — Вып. 2. — № 1. — С. 37.
Сулимов В.А. Профилактика венозных тромбоэмболий. — М.: ГЭО-
ТАР-Медиа, 2009. — 110 с.
Яковлев В.Б. Тромбоэмболия легочной артерии. Диагностика, лечение,
профилактика // РМЖ. — 1998. — № 6 (16). URL: http://www.rmj.ru/
articles_2260.htm
Berquist D. Венозная тромбоэмболия и рак: профилактика венозной
тромбоэмболии // Современная онкология. — 2002. — № 4 (3). — С. 1–6.
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
473
Литература
Sammama M., Cohen A., Darmon J.Y. и др. Сравнение эффективности
эноксапарина и плацебо в профилактике тромбозов и эмболий у паци-
ентов с острыми терапевтическими заболеваниями // Клин. фармако-
логия и терапия. — 2001. — № 10 (1). — С. 90–95.
Adolf J., Fritsche H.M., Haas S. et al. Comparison of 3,000 IU aXa of the
low molecular weight heparin Certoparin with 5,000 IU aXa in prevention
of deep vein thrombosis after total hip replacement: German Thrombosis
Study Group // Int. Angiol. — 1999. — Vol. 18. — P. 122–126.
Ageno W. Treatment of Venous Thromboembolism // Vessels. — 2000. —
Vol. 97(1). — P. 63–72.
Agnelli G., Becattini C., Kirschstein T. Thrombolysis vs heparin in the treat-
ment of pulmonary embolism: a clinical outcome-based meta-analysis //
Arch. Intern. Med. — 2002. — Vol. 162. — P. 2537–2541.
Agnelli G., Bergqvist D., Cohen A. et al. Randomized double-blind study
to compare the efficacy and safety of postoperative fondaparinux (Arixtra)
and preoperative dalteparin in the prevention of venous thromboembo-
lism after high-risk abdominal surgery: the PEGASUS Study [abstract] //
Blood. — 2003. — Vol. 102. — 15a.
Agnelli G., Pascucci В., Cosmi B. et al. The comparative effects of recom-
binant hirudin (CGP-39393) and standard heparin on thrombosis growth
in rabbis // Thromb. and Haemost. — 1990. — Vol. 63. — P. 204–207.
Agnelli G., Piovella F., Buoncristiani P. et al. Enoxaparin plus compression
stockings compared with compression stockings alone in the prevention of
VTE after elective neurosurgery // N. Engl. J. Med. — 1998. — Vol. 339. —
P. 80–85.
Agnelli G., Prandoni P., Santamaria M.G. et al. Three months versus one
year of oral anticoagulant therapy for idiopatic deep venous thrombosis //
N. Engl. J. Med. — 2001. — Vol. 345 (3). — P. 165–169.
Agnelli G., Sonaglia F. Prevention of venous throbmoembolism // Ves-
sels. — 2000. — Vol. 97 (1). — P. 49–62.
Aklog L., Williams C.S., Byrne J.G., Goldhaber S.Z. Acute pulmonary em-
bolectomy: a contemporary approach // Circulation. — 2002. — Vol. 105. —
Р. 1416–1419.
Albenc-Gelas M., Aiach M., De Moerloose P. Venous nhromboembolic
diseasea: risk factors and laboratory investigation // Semin. Vasc. Med. —
2001. — Vol. 1 (1). — Р. 81–88.
Alikhan R., Peters F., Wilmott R., Cohen A.T. Fatal pulmonary embo-
lism in hospitalised patients: a necropsy review // J. Clin. Pathol. —
2004. — Vol. 57. — Р. 1254–1257.
Amato L., Berti S., Fabbri P. Warfarin-induced skin necrosis // SKINmed. —
2003. — Vol. 2 (2). — Р. 127–130.
Ananthasubramanian K., Bcallie J.N., Rosman H.S. et. al. How safely
and for how long can warfarin therapy be withheld in prosthetic heart
valve patients hospitalized with major hemorrhage? // Chest. — 2001. —
Vol. 119. — Р. 478–484.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
474
Литература
Anderson D.R., Kahn S.R., Rodger M.A. et al. Computed tomographic pul-
monary angiography vs ventilation-perfusion lung scanning in patients
with suspected pulmonary embolism: a randomized controlled trial //
JAMA. — 2007. — Vol. 298. — Р. 2743–2753.
Anderson F.A. Jr., Spencer F.A. Risk factors for venous thromboembolism //
Circulation. — 2003. — Vol. 107 (23 Suppl. 1). — I9–16.
Anderson F.A., Huang W., Sullivan C. et al. The continuing risk of venous
thromboembolism following operation for glioma: findings from the Glio-
ma Outcomes Project [abstract] // Haemost. Thromb. — 2001. — Vol. 86
(Suppl). — OC902.
Andrea G., Ambrosio R., Di Perna P. et al. A polymorphism in the VKORC1
gene is associated with an interindividual variability in the dose-anticoagu-
lant effect of warfarin // Blood. — 2005. — Vol. 105. — P. 645–649.
Andrew M., Marzinotto V., Pencharz P. et al. A cross-sectional study of
catheter-related thrombosis in children receiving total parenteral nutrition
at home // J. Pediatr. — 1995. — Vol. 126. — P. 358–363.
Anglen J.O., Goss K., Edwards J. et al. Foot pump prophylaxis for deep
venous thrombosis: the rate of effective usage in trauma patients // Am. J.
Orthop. — 1998. — Vol. 27. — P. 580–582.
Anton N., Massicotte M.P. Venous thromboembolism in pediatrics // Se-
min. Vasc. Med. — 2001. — Vol. 1 (1). — P. 111–122.
Ariens R.A., Philippou H., Nagaswami C. et al. The factor XIII V34L poly-
morphism accelerates thrombin activation of factor XIII and affects cross-
linked fibrin structure // Blood. — 2000. — Vol. 96. — P. 988–995.
Arya R., Barnes J.A., Hossain U. et al. Long-haul flights and deep vein
thrombosis: a significant risk only when additional factors are also present //
Br. J. Haematol. — 2002. — Vol. 116. — P. 653–654.
Aschwanden M., Labs K.H., Engel H. et al. Acute deep vein thrombosis:
early mobilization does not increase the frequency of pulmonary embo-
lism // Thromb. Haemost. — 2001. — Vol. 85. — P. 42–46.
Asherson R.A. Multiorgan failure and antiphospholipid antibodies: the ca-
tastrophic antiphospholipid (Asherson’s) syndrome // Immunobio logy. —
2005. — Vol. 210 (10). — P. 727–733.
Asherson R.A., Espinosa G., Cervera R. et al. Catastrophic antiphospholi-
pid syndrome: proposed guidelines for diagnosis and treatment // J. Clin.
Rheumatol. — 2002. — Jun.; Vol. 8 (3). — P. 157–165.
ATAC (Arimidex Tamoxifen Alone or in Combination) Trialists’ Group.
Anastrozole alone or in combination with tamoxifen versus tamoxifen alone
for adjuvant treatment of postmenopausal women with early breast cancer:
first results of the ATAC randomised trial // Lancet. — 2002. — Vol. 359. —
P. 2131–2139.
Attia J., Ray J.G., Cook D.J. et al. Deep vein thrombosis and its prevention in
critically ill adults // Arch. Intern. Med. — 2001. — Vol. 161. — P. 1268–1279.
Aujesky D., Roy P.M., Guy M. et al. Prognostic value of D-dimer in patients with
pulmonary embolism // Thromb. Haemost. — 2006. — Vol. 96. — Р. 478–482.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
39.
475
Литература
Babikian V.L., Kase C.S., Pessin M.S. et al. Resumption of anticoagulation
after inlracranial bleeding in patients with prosthetic heart valves [let-
ter] // Stroke. — 1988. — Vol. 19. — P. 407–408.
Baglin T.P., White K., Charles A. Fatal pulmonary embolism in hospitalized
medical patients // J. Clin. Pathol. — 1997. — Vol. 50. — P. 609–610.
Balas E.A., Weingarten S., Garb C.T. et al. Improving preventive care by prompt-
ing physicians // Arch. Intern. Med. — 2000. — Vol. 160. — P. 301–308.
Barclay L. Low-Dose Warfarin prevents recurrent venous thromboembo-
lism // New Engl. J. Med. Published online. — 2003. — Feb. 24.
Barclay L. Low-dose wrafarin prevents recurrent venous thromboembo-
lism // Medscape Medical. News. — 2003.
Barth J., Rohl K., Jager D. Protein-z-deficiency as a rare case of periop-
erative bleeding // Anasthesiol. Intensivmed Notfallmed Schmerzther. —
2003. — Vol. 38 (9). — P. 605–608.
Bates S.M., Ginsberg J.S. Pregnancy and deep vein thrombosis // Semin.
Vasc. Med. — 2001. — Vol. 1 (1). — P. 96–104.
Bates S.M., Greer I.A., Hirsh J., Ginsberg J.S. Use of antithrombotic agents
du ring pregnancy // Chest. — 2004. — Vol. 126 (Suppl.). — 627S–644S.
Bates S.M., Greer I.A., Pabinger I. et al. Venous Thromboembolism, Throm-
bophilia, Antithrombotic Therapy and Pregnancy The 8th ACCP Con-
ference on antithrombotic and thrombolytictherapy // Chest. — 2008. —
Vol. 133/6. — 844S–886SK.
Bates Sh. M. Management of Pregnant Women with Thrombophilia or
a History of Venous Thromboembolism // American Society of Hemato-
logy Education Program Book. Atlanta, Georgia. — 2007. — Dec. 8–11. —
P. 143–150.
Bauer K.A. Recent progress in anticoagulant therapy: oral direct in-
hibitors of thrombin and factor Xa // J. Thromb. Haemost. — 2011. —
Vol. 9 (Suppl. 1). — S. 12–19.
Bauer K.A., Eriksson B.I., Lassen M.R., Turpie A.G.G. Fondaparinux com-
pared with enoxaparin for the prevention of venous thromboembolism after
elective major knee surgery // New Engl. J. Med. — 2001. — Vol. 345. —
P. 1305–1310.
Bauersachs R.M., Dudenhausen J., Faridi A. et al. Risk stratification and
heparin prophylaxis to prevent venous thromboembolism in pregnant
women // Thromb. Haemost. — 2007. — Vol. 98. — P. 1237–1245.
Baughman R.A., Kapoor S.C., Agarwal R.J. et al. Oral delivery of antico-
agulant doses of heparin: a randomized, double-blind, controlled study in
humans // Circulation. — 2001. — Vol. 98. — P. 1610–1615.
Baykal C.A., Demirtas E. et al. Comparison of enoxaparin and standard
heparin in gynaecologic oncologic surgery: a randomised prospective dou-
ble-blind study // Eur. J. Gynaecol. Oncol. — 2001. — Vol. 22. — P. 127–130.
Beasley R., Raymond N., Hill S. et al. eThrombosis: the 21st century
variant of venous thromboembolism associated with immobility // Eur.
Respir. J. — 2003. — Vol. 21. — P. 374–376.
40.
41.
42.
43.
44.
45.
46.
47.
48.
49.
50.
51.
52.
53.
54.
55.
476
Литература
Belcaro G., Cesarone M.R., Nicolaides A. et al. Prevention of flight venous
thrombosis in high risk subjects with stockings or one-dose enoxaparain
[abstract] // Circulation. — 2002. — Vol. 106 (Suppl.). — S. 711–721.
Belcaro G., Cesarone M.R., Shah S.S.G. et al. Prevention of edema, flight
microangiopathy and venous thrombosis in long flights with elastic stock-
ings: a randomized trial; the LONFLIT 4 Concorde Edema-SSL Study //
Angiology. — 2002. — Vol. 53. — P. 635–645.
Belcaro G., Geroulakos G., Nicolaides A.N. et al. Venous thromboembolism
from air travel: the LONFLIT Study // Angiology. — 2001. — Vol. 52. —
P. 369–374. URL: http://www.chestjournal.org/cgi/external_ref?access_
num=000169511600001&link_type=ISI
Bendz B., Sandset P.M. Air travel and risk of venous thromboembolism //
Thromb. Res. — 2002. — Vol. 108 (1). — P. 3–13.
Bergmann J.-F., Neuhart E. A multicentral randomized doubleblind study
of enoxiparin compared with unfraction heparin in the prevention of ve-
nous thromboembolic desease in elderlyin-patients bedridden for an acute
medical illneaa // Thromb. Haemost. — 1996. — Vol. 76. — P. 529–534.
Bergqvist D., Benoni G., Bjцrgell O. et al. Low-molecular-weight heparin
(enoxaparin) as prophylaxis against VTE after total hip replacement //
New Engl. J. Med. — 1996. — Vol. 335. — P. 696–700.
Bernard G.R., Vincent J.L., Laterre P.F. et al. Efficacy and safety of recom-
binant activated protein C for sever sepsis // New Engl. J. Med. — 2001. —
Vol. 344. — P. 699–709.
Bernardi E., Bagatella P., Frulla M., Simiona P., Prandony P. Posttthom-
botic syndrome: incidence, prevention and management // Semin. Vasc.
Med. — 2001. — Vol. 1 (1). — P. 71–80.
Bernardi E., Piccioli A., Marcbiori A. et al. Upper extremity deep vein
thrombosis: risk factora, diagnosis, and management // Semin. Vasc.
Med. — 2001. — Vol. 1 (1). — P. 105–110.
Bezemer I.D., Bare L.A., Doggen C.J. et al. Gene variants associated with
deep vein thrombosis // JAMA. — 2008. — Vol. 299. — P. 1306–1314.
Blanchard J., Meuwly J.-Y., Leyvraz P.-F. et al. Prevention of deep-vein throm-
bosis after total knee replacement: randomised comparison between a low-mo-
lecular-weight heparin (nadroparin) and mechanical prophylaxis with a foot-
pump system // J. Bone Joint. Surg. Br. — 1999. — Vol. 81. — P. 654–659.
Blebea J., Wilson R., Waybill P. et al. Deep venous thrombosis after percu-
taneous insertion of vena caval filters // J. Vasc. Surg. — 1999. — Vol. 30. —
P. 821–829.
Blinder D., Manor Y., Martinowitz U. et al. Dental extractions in patients
maintained on continued oral anticoagulant: Comparison of local hemo-
static modalities // Oral Surg. Oral Med. Oral Pathol. Oral Radiol. En-
dod. — 1999. — Vol. 88. — P. 137–140.
Bloemenkamp K.W.M., Rosendaal F.R., Helmerhorst F.M. et al. Higher risk of
venous thrombosis during early use of oral contraceptives in women with in-
herited clotting defects //Arch. Intern. Med. — 2000. — Vol. 160. — P. 49–52.
56.
57.
58.
59.
60.
61.
62.
63.
64.
65.
66.
67.
68.
69.
477
Литература
Blom J.W., Doggen C.J., Osanto S., Rosendal F.R. Malignancies prothrom-
botic mutations and the risk of venous thrombosis // JAMA. — 2005. —
Vol. 293. — P. 715–723.
Bona R.D. Thrombotic complications of central venous catheters in cancer
patients // Semin. Thromb. Hemost. — 1999. — Vol. 25. — P. 147–155.
Bonnar J. Can more be done in obstetric and gynecologic practice to reduce
morbidity and mortality associated with VTE? // Am J. Obstet. Gyne-
col. — 1999. — Vol. 180. — P. 784–791.
Bounameaux H., Perrier A., Wells P.S. Clinical and laboratory diagno-
sis of deep vein thrombosis: new cost-effectife strategies // Semin. Vasc.
Med. — 2001. — Vol. 1 (1). — P. 39–43.
Branch D.W., Peaceman A.M., Druzin M. et al. A multicenter, placebo-
controlled pilot study of intravenous immune globulin treatment of an-
tiphospholipid syndrome during pregnancy // Am. J. Obstet. Gynecol. —
2000. — Vol. 182. — P. 122–127.
Brandjes D.P.M., Buller H.R., Heijboer H. et al. Randomised trial of ef-
fect of compression stockings in patients with symptomatic proximal-vein
thrombosis // Lancet. — 1997. — Vol. 349. — P. 759–762.
Bratzler D.W., Raskob G.E., Murray C.K. et al. Underuse of Venous Throm-
boembolism prophylaxis for general surgery patients // Arch. Intern.
Med. — 1998. — Vol. 158. — P. 1909–1912.
Brennand J.E., Greer I.A. Thromboembolism in gynaecological surgery //
Curr. Obstet. Gynaecol. — 1998. — Vol. 8. — P. 44–48.
Brett A.S. Thrombolytic therapy of submassive pulmonary embolism? // J.
Watch. — 2002. — Vol. 18. — P. 7.
Brey R.L. New treatment option for the antiphospholipid antibody syn-
drome? More pleotropc effects of the statin drugs // J. Thromb. Hae-
most. — 2004. — Vol. 2. — P. 1556–1557.
Brischetto M.J., Brischetto M.A., Auer A. et al. Venous thrombosis in burn pa-
tients [abstract] // Am. J. Respir. Crit. Care Med. — 1998. — Vol. 157. — P. 768.
Buller H.R., Agnelli G., Hull R.D. et al. Antithrombotic therapy for venous
thromboembolic disease. Theseventh ACCP Conference on antithrombotic
and thrombolytictherapy // Chest. — 2004. — Vol. 126/3. — P. 401–428.
Buller H.R., Davidson B.L., Decousus H. et al. Subcutaneous fondaparinux
versus intravenous unfractionated heparin in the initial treatment of pulmo-
nary embolism // New Engl. J. Med. — 2003. — Vol. 349. — P. 1695–1702.
Burihan E., De Figueiredo L.F., Francisco J.J. et al. Upper-extremity deep
venous thrombosis: analysis of 52 cases // Cardiovasc. Surg. — 1993. —
Vol. 1. — P. 19–22.
Bоchan J.S. Thrombolysis for subvassive pulmonary embolism // J. Watch
Emergency Med. — 2002. — Vol. 26; 1 (8). — P. 456–457.
Cain R.L., Spiess B.D., Nelson M., Deanda A. Jr. et al. Bivalirudin anticoa-
gulation for a patient with hypercoagulable immune syndromes undergo-
ing mitral valve surgery //Ann. Thorac. Surg. — 2006. — Jun.; 81(6). —
P. 2308–2310.
70.
71.
72.
73.
74.
75.
76.
77.
78.
79.
80.
81.
82.
83.
84.
85.
478
Литература
Camm A.J., Kirchhof P., Lip G.Y.H. et al. Guidelines for the management
of atrial fibrillation: The Task Force for the Management of Atrial Fibrilla-
tion of the European Society of Cardiology (ESC) // Europ. Heart J.URL:
http://www.doi:10.1093/eurheartj/ehq278
Cannegieter S.C., Doggen C.J., Van Houwelingen H.C., Rosendaal F.R. Tra-
vel-related venous thrombosis: results from a large population-based case
control study (MEGA study) // PLoS Med. — 2006. — Vol. 3. — P. 307.
Caprini J.A., Botteman M.F., Stephens J.M. et al. Economic burden of long-
term complications of deep vein thrombosis after total hip replacement sur-
gery in the United States // Value Health. — 2003. — Vol. 6. — P. 59–74.
Caprini J.A., Motykie G., Arcelus J.I. et al. Prevention of VTE by general
surgeons in North America: results of a survey // Int. Angiol. — 1999. —
Vol. 8. — P. 181–182.
Carter C.J. The natural history and epidemiology of venous thrombosis //
Prog. Cardiovasc. Dis. — 1994. — Vol. 36. — P. 423–438.
Catre M.G. Anticoagulation in spinal surgery: a critical review of the lite-
rature // Can. J. Surg. — 1997. — Vol. 40. — P. 413–419.
Cerianie E., Combescure C., Gal L.E. et al. Clinical prediction rules for
pulmonary embolism: a systematic review and meta-analysis // J. Thromb.
Haemost. — 2010. — Vol. 8. — P. 957–970.
Cesarone M.R., Belcaro G., Errichi B.M. et al. The LONFLIT4-Concorde
Deep Venous Thrombosis and Edema Study: prevention with travel stock-
ings // Angiology. — 2003. — Vol. 54. — P. 143–154.
Cesarone M.R., Belcaro G., Nicolaides A.N. et al. Venous thrombosis from
air travel: the LONFLIT3 study: prevention with aspirin vs low-molecu-
lar-weight heparin (LMWH) in high-risk subjects; a randomized trial //
Angiology. — 2002. — Vol. 53. — P. 1–6.
Chan W.S., Anand S., Ginsberg J.S. Anticoagulation of pregnant women
with mechanical heart valves: a systematic review of literture // Arch.
Intern. Med. — 2000. — Vol. 160. — P. 191–196.
Chan W.S., Ray J.G., Murray S. et al. Suspected pulmonary embolism
in pregnancy: clinical presentation, results of lung scanning, and subse-
quent maternal and pediatric outcomes // Arch. Intern. Med. — 2002. —
Vol. 162. — P. 1170–1175.
Chartier L., Bera J., Delomez M., Asseman P. et al. Free-floating thrombi
in the right heart: diagnosis, management, and prognostic indexes in 38
consecutive patients // Circulation. — 1999. — Vol. 99. — P. 2779–2783.
Chen D., Apple D.F., Hudson L.M. et al. Medical complications during acute
rehabilitation following spinal cord injury — current experience of the Model
Systems // Arch. Phys. Med. Rehabil. — 1999. — Vol. 80. — P. 1397–1401.
Chew H.K., Wun T., Harvey D. et al. Incidence of venous thromboembolism
and its effect on survival among patients with common cancers // Arch.
Intern. Med. — 2006. — Vol. 166. — P. 458–464.
Choay J., Petitou M., Lormeau J.C., Sinaя P. et al.
Structure-activity re-
lationship in heparin: a synthetic pentasaccharide with high affinity for
86.
87.
88.
89.
90.
91.
92.
93.
94.
95.
96.
97.
98.
99.
100.
479
Литература
antithrombin III and eliciting high anti-factor Xa activity // Biochem.
Biophys. Res. Commun. — 1983. — Vol. 116. — P. 492–499.
Ciccone W.J., Fox P.S., Neumyer M. et al. Ultrasound surveillance for
asymptomatic deep venous thrombosis after total joint replacement //
J. Bone Joint. Surg. Am. — 1998. — Vol. 80. — P. 1167–174.
Clagett G.P., Anderson F.A., Geerts W. et al. Prevention of venous throm-
boembolism // Chest. — 1998. — Vol. 114. — 531S–60S.
Cohen A.T., Gallus A.S., Lassen M.R. et al. Fondaparinux vs placebo for
the prevention of venous thromboembolism in acutely ill medical patients
(ARTEMIS). Program and abstracts of the XIX Congress of the Inter-
national Society on Thrombosis and Haemostasis. Birmingham, UK, July
12–18, 2003. — P. 2406.
Cohen A.T., Tapson V.F., Bergmann J.F. et al. Venous thromboembolism
risk and prophylaxis in the acute hospital care setting (ENDORSE study):
a multinational cross-sectional study // Lancet. — 2008. — Vol. 371. —
P. 387–394.
Cohn S.M., Moller B.A., Feinstein A.J. et al. Prospective trial of low-mo-
lecular-weight heparin versus unfractionated heparin in moderately injured
patients // Vasc. Surg. — 1999. — Vol. 33. — P. 219–223.
Colditz G.A., Tuden R.L., Oster G. Rates of venous thrombosis after ge-
neral surdgery: Combined results of randomized clinical trials // Lancet. —
1986. — Vol. 19. — P. 143–146.
Collins R., Scrimgeour A., Yusuf S. et al. Reduction in fatal pulmonary embo-
lism and venous thrombosis by operioperative administration of cubcutaneous
heparin. Overview of results and randomized trials in general, orthopaedic and
urologic surgery // New Engl. J. Med. — 1988. — Vol. 318. — P. 1162–1173.
Colman R.W., Hissh J., Marder V.J., Salzman E.W. Haemostasis and thrombo-
sis. Basic princeplen and clinical practice. — 2
nd
ed. — Philadelphia, London,
Mexico city, Sao Paulo, Sydney: L.B. Lippicott company, 1987. — P. 1507.
Colwell C.W., Berkowitz S.D., Comp P.C. et al. Randomized, double-blind
comparison of ximelagatran, an oral direct thrombin inhibitor, and warfarin
to prevent venous thromboembolism (VTE) after total knee replacement
(TKR): EXULT B [abstract] // Blood. — 2003. — Vol. 102. — 14a.
Colwell C.W., Berkowitz S.D., Davidson B.L. et al. Comparison of ximelagat-
ran, an oral direct thrombin inhibitor, with enoxaparin for the prevention
of venous thromboembolism following total hip replacement: a randomized,
double-blind study // J. Thromb. Haemost. — 2003. — P. 2119–2130.
Colwell C.W., Collis D.K., Paulson R. et al. Comparison of enoxaparin and
warfarin for the prevention of venous thromboembolic disease after total
hip arthroplasty: evaluation during hospitalization and three months after
discharge // J. Bone Joint. Surg. Am. — 1999. — Vol. 81. — P. 932–940.
Colwell C.W., Spiro T.E., Trowbridge A.A. et al. Efficacy and safety of
enoxaparin versus unfractionated heparin for prevention of deep venous
thrombosis after elective knee arthroplasty // Clin. Orthop. — 1995. —
Vol. 321. — P. 19–27.
101.
102.
103.
104.
105.
106.
107.
108.
109.
110.
111.
112.
480
Литература
Comerota A.J., Chouhan V., Harada R.N. et al. The fibrinolytic effects of
intermittent pneumatic compression: mechanism of enhanced fibrinoly-
sis // Ann. Surg. — 1997. — Vol. 226. — P. 306–313.
Comerota A.J., Katz M.L., Greenwald L.L. et al. Venous duplex ima -
ging: should it replace hemodynamic tests for deep venous thrombosis? //
J. Vasc. Surg. — 1990. — Vol. 11. — P. 53–61.
Comp P.C. Selective Factor Xa Inhibition improves efficacy of venous
thromboembolism prophylaxis in orthopedic surgery // Pharmacothe-
rapy. — 2003. — Vol. 23 (6). — P. 772–787.
Comp P.C., Trowbridge A., Voegeli T. et al. A comparison of danaparoid
and warfarin for prophylaxis against deep vein thrombosis after total hip
replacement // Orthopedics. — 1998. — Vol. 21. — P. 1123–1128.
Consortium for spinal cord medicine prevention of thromboembolism in
spinal cord injury // J. Spinal. Cord. Med. — 1997. — Vol. 20. — P. 259–283.
Cosmi B., Legnani C., Cini M., Guazzaloca G., Palareti G. Dimer levels
in combination with residual venous obstri, and the risk of recurrence af-
ter anticoagulation withdra for a first idiopathic deep vein thrombosis //
Thromb. Haemost. — 2005. — Vol. 94. — P. 969–974.
Couban S., Goodyear M., Burnell M. et al. A randomized double-blind
placebo-controlled study of low dose warfarin for the prevention of symp-
tomatic central venous catheter-associated thrombosis in patients with
cancer [abstract] // Blood. — 2002. — Vol. 100 (Suppl.). — 703a.
Couturraud F., Kearon C. Treatment of deep vein thrombosis // Semin.
Vasc. Med. — 2001. — Vol. 1 (1). — P. 43–55.
Creager M., Dzau V. Vascular Disease of the Extremities // In Harrison’s
principles of internal disease. — 16
th
ed. — 2005. — P. 1486–1494.
Crowther M.A., Ginsberg J.S., Julian J. et al. A comparison of two intensi-
ties of warfarin for the prevention of recurrent thrombosis in patients with
the antiphospholipid antibody syndrome // New Engl. J. Med. — 2003. —
Vol. 349. — P. 1133–1138.
Dahl O.E., Andreassen G., Aspelin T. et al. Prolonged thromboprophylaxis
following hip replacement surgery — results of a double-blind, prospec-
tive, randomised, placebo-controlled study with dalteparin (Fragmin) //
Thromb. Haemost. — 1997. — Vol. 77. — P. 26–31.
Dahl O.E., Gudmundsen T.E., Haukeland L. Late occurring clinical deep
vein thrombosis in joint-operated patients // Acta Orthop. Scand. —
2000. — Vol. 71. — P. 47–50.
Dahlbдck B. Resistance to activated protein C as risk factor for thrombo-
sis: molecular mechanisms, laboratory investigation, and clinical manage-
ment // Semin. in hematol. — 1997. — Vol. 34 (3). — P. 217–234.
Dahlbдck B., Stenflo J. The protein C anticoagulant system, in stamatoyan-
nopoulos // In: The molecular basis of blood diseases / Eds. A.W. Nienhuis,
P.W. Majerus et. al. — Philadelphia: Saunders, 1994. — P. 599–628.
Daiichi Sankyo Europe Gmbh Anticoagulants. A Guide through acronyms
and major clinical trials. — 2011. — P. 234.
113.
114.
115.
116.
117.
118.
119.
120.
121.
122.
123.
124.
125.
126.
127.
Соседние файлы в папке Библиотека им академика М.И. Перельмана